PRVA
Privia Health Group, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
-13/100
Last price
20.28
▼ 0.17 (0.83%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
20.71
Prev close
20.45
Day high
20.88
Day low
20.26
Volume
1.08M
Market cap
$2.59B
P/E (TTM)
96.57
52W range
18.92 – 28.82
Day trading desk
Gap from prior close
+1.27%
Prior close 20.45
VWAP
20.35
-0.35% from price
Relative volume
1.53×
Unusually busy
Session range
3.06%
20.26 – 20.88
Position in range
3%
Near session low
ATR (14D)
0.58
2.87% of price
Prior day high
20.55
PDH
Prior day low
20.22
PDL
Bid / ask spread
—
Quote not published
Session volume
1.88M
Avg 1.23M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.36%
+1.4%
1M
-1.84%
-3.0%
3M
-25.47%
-30.0%
6M
-9.38%
-27.6%
YTD
-14.47%
-28.7%
1Y
-15.82%
-32.2%
3Y
-11.83%
-94.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PRVA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-97.03K
Net selling
Buy transactions
15
517.33K shares
Sell transactions
11
614.35K shares
Net transactions
+26
Buys less sells
Sell : buy shares
1.2 : 1
Mixed
Insider-held shares
7.91M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 9, 26 | MOUNTCASTLE DAVID Chief Financial Officer |
SELL | 21.27K | $588.68K | Direct |
| Jul 7, 26 | MOUNTCASTLE DAVID Chief Financial Officer |
SELL | 600 | $16.54K | Direct |
| Jul 6, 26 | MORRIS MATTHEW SHAWN Director |
CONVERSION | 112.76K | $225.52K | Direct |
| Jul 6, 26 | MORRIS MATTHEW SHAWN Director |
SELL | 112.76K | $3.08M | Direct |
| Jul 2, 26 | MOUNTCASTLE DAVID Chief Financial Officer |
SELL | 24.73K | $680.18K | Direct |
| Jul 1, 26 | MORRIS MATTHEW SHAWN Director |
CONVERSION | 135.50K | $271.00K | Direct |
| Jul 1, 26 | MORRIS MATTHEW SHAWN Director |
SELL | 135.50K | $3.57M | Direct |
| Jun 29, 26 | MORRIS MATTHEW SHAWN Director |
CONVERSION | 151.32K | $302.64K | Direct |
| Jun 29, 26 | MORRIS MATTHEW SHAWN Director |
SELL | 151.32K | $3.83M | Direct |
| Jun 26, 26 | MOUNTCASTLE DAVID Chief Financial Officer |
CONVERSION | 17.20K | $34.39K | Direct |
| Jun 26, 26 | MOUNTCASTLE DAVID Chief Financial Officer |
SELL | 17.20K | $433.00K | Direct |
| May 20, 26 | SOISTMAN FRANCIS S JR Director |
STOCK | 8.46K | $0 | Direct |
| May 20, 26 | BERBERIAN LANCE V Director |
STOCK | 8.46K | $0 | Direct |
| May 20, 26 | KIMMET PAMELA O'BRIEN Director |
STOCK | 8.46K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
COCOZZA NANCY G |
Director | 42.81K | Stock Award(Grant) |
FARGIS EDWARD C. |
General Counsel | 111.98K | Stock Award(Grant) |
KING DAVID P |
Director | 50.77K | Stock Award(Grant) |
MARYLAND PATRICIA ANNE |
Director | 42.31K | Stock Award(Grant) |
MCCARTHY THOMAS A |
Director | 69.47K | Stock Award(Grant) |
MEHROTRA PARTH |
Chief Executive Officer | 434.36K | Sale |
MORRIS MATTHEW SHAWN |
Director | 92.67K | Conversion of Exercise of derivative security |
MOUNTCASTLE DAVID |
Chief Financial Officer | 173.55K | Sale |
RYU JAEWON |
Director | 47.11K | Stock Award(Grant) |
WICHMANN DAVID S |
Director | 1.34M | Stock Award(Grant) |
Fundamentals
Market cap$2.59B
Enterprise value$2.24B
Revenue (TTM)$2.36B
Gross profit$236.52M
EBITDA$56.94M
Net income$28.12M
EPS (TTM)$0.21
Free cash flow$95.65M
Total cash$412.20M
Total debt$8.73M
Book value / share$6.20
Shares outstanding127.73M
Float108.95M
Short % of float5.69%
Dividend yield0.00%
Beta (5Y)0.80
Valuation & profitability ratios
Trailing P/E96.57
Forward P/E19.11
PEG ratio—
Price / sales—
Price / book3.27
EV / revenue0.95
EV / EBITDA39.39
Gross margin10.03%
Operating margin1.86%
Profit margin1.19%
Return on equity4.31%
Return on assets2.03%
Debt / equity1.04
Current ratio1.62
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.12B | $1.74B | $1.66B | $1.36B | +22.3% |
| Operating revenue | $2.11B | $1.73B | $1.65B | $1.35B | +22.3% |
| Cost of revenue | $1.91B | $1.56B | $1.50B | $1.22B | +22.7% |
| Gross profit | $209.43M | $176.85M | $161.50M | $134.78M | +18.4% |
| Selling, general & admin | $165.29M | $152.60M | $134.32M | $149.33M | +8.3% |
| Total operating expense | $175.19M | $159.87M | $140.85M | $153.90M | +9.6% |
| Operating income | $34.23M | $16.98M | $20.65M | -$19.12M | +101.6% |
| Net interest income | $9.70M | $10.89M | $8.37M | $542.00K | -10.9% |
| Pre-tax income | $43.94M | $27.87M | $29.02M | -$18.58M | +57.7% |
| Tax provision | $14.21M | $10.83M | $7.99M | -$6.52M | +31.3% |
| Net income | $22.92M | $14.38M | $23.08M | -$8.59M | +59.3% |
| Net income to common | $22.92M | $14.38M | $23.08M | -$8.59M | +59.3% |
| Basic EPS | 0.19 | 0.12 | 0.20 | -0.08 | +58.3% |
| Diluted EPS | 0.19 | 0.11 | 0.19 | -0.08 | +72.7% |
| EBIT | $34.23M | $16.98M | $20.65M | -$19.12M | +101.6% |
| EBITDA | $44.14M | $24.25M | $27.18M | -$14.55M | +82.0% |
| Basic shares | 122.18M | 119.40M | 116.73M | 110.70M | +2.3% |
| Diluted shares | 128.89M | 125.61M | 124.69M | 110.70M | +2.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $479.69M | $491.15M | $389.51M | $347.99M | — | -2.3% |
| Cash & short-term investments | $479.69M | $491.15M | $389.51M | $347.99M | — | -2.3% |
| Accounts receivable | $400.90M | $316.18M | $290.77M | $189.60M | — | +26.8% |
| Total current assets | $911.00M | $834.82M | $700.80M | $551.96M | — | +9.1% |
| Property, plant & equipment | $9.30M | $6.07M | $8.94M | $11.47M | — | +53.2% |
| Goodwill & intangibles | $425.76M | $251.42M | $246.38M | $184.32M | — | +69.3% |
| Total assets | $1.37B | $1.14B | $999.90M | $792.81M | — | +20.6% |
| Total current liabilities | $568.52M | $449.15M | $386.95M | $264.27M | — | +26.6% |
| Current debt | — | — | — | — | $875.00K | — |
| Long-term debt | — | — | — | — | $31.69M | — |
| Total debt | $9.53M | $5.59M | $8.29M | $11.50M | — | +70.5% |
| Total liabilities | $578.43M | $452.34M | $392.51M | $273.76M | — | +27.9% |
| Retained earnings | -$156.31M | -$179.23M | -$193.61M | -$216.69M | — | +12.8% |
| Shareholder equity | $737.22M | $635.18M | $561.44M | $499.09M | — | +16.1% |
| Working capital | $342.48M | $385.68M | $313.85M | $287.69M | — | -11.2% |
| Net tangible assets | $311.46M | $383.76M | $315.06M | $314.77M | — | -18.8% |
| Shares issued | 123.60M | 120.31M | 118.22M | 114.69M | — | +2.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $29.73M | $17.04M | $21.03M | -$12.06M | — | +74.4% |
| Depreciation & amortisation | $9.91M | $7.27M | $6.53M | $4.57M | — | +36.3% |
| Stock-based compensation | $71.07M | $56.68M | $37.10M | $67.36M | — | +25.4% |
| Change in working capital | $41.83M | $19.47M | $8.66M | -$6.35M | — | +114.8% |
| Operating cash flow | $163.40M | $109.28M | $80.78M | $47.20M | — | +49.5% |
| Capital expenditure | — | — | -$113.00K | -$104.00K | -$547.00K | — |
| Investing cash flow | -$181.57M | -$11.98M | -$42.97M | -$104.00K | — | -1,415.9% |
| Financing cash flow | $6.70M | $4.33M | $3.71M | -$19.68M | — | +54.6% |
| Free cash flow | $163.40M | $109.28M | $80.78M | $47.20M | — | +49.5% |
| End cash position | $479.69M | $491.15M | $389.51M | $347.99M | — | -2.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $632.63M | $603.85M | $541.17M | $580.42M | $521.15M | +4.8% |
| Operating revenue | $630.66M | $601.51M | $538.70M | $578.11M | $519.03M | +4.8% |
| Cost of revenue | $569.84M | $543.54M | $491.52M | $516.65M | $470.91M | +4.8% |
| Gross profit | $62.79M | $60.31M | $49.66M | $63.77M | $50.24M | +4.1% |
| Selling, general & admin | $47.66M | $49.61M | $35.72M | $46.60M | $44.32M | -3.9% |
| Total operating expense | $51.02M | $52.89M | $38.38M | $49.37M | $46.91M | -3.5% |
| Operating income | $11.77M | $7.42M | $11.28M | $14.40M | $3.34M | +58.6% |
| Net interest income | $1.67M | $1.89M | $2.09M | $2.27M | $2.41M | -11.7% |
| Pre-tax income | $16.75M | $9.31M | $13.37M | $16.67M | $5.74M | +79.9% |
| Tax provision | $7.02M | $5.60M | $2.79M | $6.87M | $2.46M | +25.3% |
| Net income | $9.05M | $3.06M | $9.15M | $6.86M | $2.69M | +195.3% |
| Net income to common | $9.05M | $3.06M | $9.15M | $6.86M | $2.69M | +195.3% |
| Basic EPS | 0.07 | 0.02 | 0.07 | 0.06 | 0.02 | +250.0% |
| Diluted EPS | 0.07 | 0.02 | 0.07 | 0.05 | 0.02 | +250.0% |
| EBIT | $11.77M | $7.42M | $11.28M | $14.40M | $3.34M | +58.6% |
| EBITDA | $15.13M | $10.70M | $13.94M | $17.17M | $5.92M | +41.4% |
| Basic shares | 126.12M | 124.15M | 123.19M | 122.77M | 122.13M | +1.6% |
| Diluted shares | 131.83M | 130.88M | 130.37M | 128.78M | 128.45M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $412.20M | $419.52M | $479.69M | $441.35M | $390.13M | -1.7% |
| Cash & short-term investments | $412.20M | $419.52M | $479.69M | $441.35M | $390.13M | -1.7% |
| Accounts receivable | $574.16M | $513.68M | $400.90M | $499.04M | $443.99M | +11.8% |
| Total current assets | $1.03B | $966.02M | $911.00M | $970.93M | $882.96M | +6.1% |
| Property, plant & equipment | $8.31M | $8.69M | $9.30M | $6.33M | $6.87M | -4.4% |
| Goodwill & intangibles | $434.44M | $422.63M | $425.76M | $339.75M | $342.36M | +2.8% |
| Total assets | $1.49B | $1.42B | $1.37B | $1.35B | $1.27B | +5.0% |
| Total current liabilities | $634.44M | $601.30M | $568.52M | $582.91M | $534.85M | +5.5% |
| Total debt | $8.73M | $9.02M | $9.53M | $6.24M | $6.64M | -3.2% |
| Total liabilities | $650.51M | $611.99M | $578.43M | $588.23M | $539.00M | +6.3% |
| Retained earnings | -$144.20M | -$153.25M | -$156.31M | -$165.46M | -$172.32M | +5.9% |
| Shareholder equity | $782.33M | $753.06M | $737.22M | $709.12M | $682.86M | +3.9% |
| Working capital | $390.82M | $364.72M | $342.48M | $388.01M | $348.11M | +7.2% |
| Net tangible assets | $347.89M | $330.43M | $311.46M | $369.37M | $340.50M | +5.3% |
| Shares issued | 126.29M | 125.69M | 123.60M | 122.87M | 122.67M | +0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $9.73M | $3.71M | $10.59M | $9.81M | $3.29M | +162.4% |
| Depreciation & amortisation | $3.36M | $3.28M | $2.66M | $2.77M | $2.58M | +2.3% |
| Stock-based compensation | $19.40M | $21.92M | $15.45M | $18.98M | $18.85M | -11.5% |
| Change in working capital | -$32.54M | -$80.91M | $97.27M | $13.78M | -$17.71M | +59.8% |
| Operating cash flow | $1.10M | -$49.47M | $127.50M | $51.99M | $7.97M | +102.2% |
| Investing cash flow | -$11.46M | -$26.00K | -$91.31M | -$1.20M | -$89.06M | -43,988.5% |
| Financing cash flow | $3.04M | -$10.67M | $2.15M | $431.00K | $1.88M | +128.5% |
| Free cash flow | $1.10M | -$49.47M | $127.50M | $51.99M | $7.97M | +102.2% |
| End cash position | $412.20M | $419.52M | $479.69M | $441.35M | $390.13M | -1.7% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.21
Positioning, not flow
Max pain
20.00
-1.4% from spot
ATM implied vol
77.4%
Nearest strike to spot
Skew (10% OTM)
+24.2%
Puts bid over calls
Call volume
12
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
20.00
12 contracts
Heaviest put OI
20.00
3 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.24 | 0.19 | -22.2% |
| Mar 2026 | 0.25 | 0.19 | -24.1% |
| Dec 2025 | 0.19 | 0.25 | +30.2% |
| Sep 2025 | 0.22 | 0.29 | +33.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.24 | 10 | $610.62M | +5.2% |
| Next quarter | 0.25 | 10 | $611.30M | +13.0% |
| Current year | 0.89 | 10 | $2.46B | +15.8% |
| Next year | 1.06 | 10 | $2.70B | +9.7% |
Analyst targets & ownership
Mean target$31.47
High target$40.00
Low target$24.00
Implied upside55.18%
Analyst count17
ConsensusSTRONG BUY
Strong buy / Buy5 / 12
Hold1
Sell / Strong sell0 / 0
Held by insiders6.19%
Held by institutions98.53%
Institutions holding399
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
19.84
+2.20% from price
SMA 20
20.01
+1.35% from price
SMA 50
21.16
-4.16% from price
SMA 100
22.75
-10.86% from price
SMA 200
22.83
-11.17% from price
EMA 12
20.04
+1.17% from price
EMA 26
20.35
-0.36% from price
EMA 50
21.15
-4.13% from price
RSI (14)
48.2
Neutral
MACD (12,26,9)
-0.31
Hist 0.18
ATR (14)
0.58
2.87% of price
Realised vol 30D
18.8%
Annualised
Bollinger upper
20.90
20, 2σ
Bollinger lower
19.12
20, 2σ
50 / 200 cross
Death
21.16 vs 22.83
Trend bias
Below 200
-11.17%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.59
Less volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
18.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-32.0%
Peak to trough
Max drawdown 5Y
-62.6%
Peak to trough
ATR 14
0.58
2.87% of price
Beta (reported)
0.80
5Y monthly, from filing
Short interest
Shares short
4.90M
Prior 5.29M
Change vs prior
-7.3%
Shorts covering
% of float
5.69%
Normal
% of shares out
3.84%
Against total outstanding
Days to cover
4.6
Liquid
Float
108.95M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 26, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 8, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Apr 8, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Mar 25, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Mar 3, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Mar 2, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Feb 27, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Dec 4, 25 | Stephens & Co. | MAINTAINED | Overweight | Overweight |
| Nov 13, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Nov 13, 25 | BMO Capital | INITIATED | — | Outperform |
| Nov 12, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Nov 10, 25 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-18
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-07
Corporate Changes & Voting Matters
8-K · 2026-05-22
Periodic Financial Reports
10-Q · 2026-05-07
Annual Report to Shareholders
ARS · 2026-04-02
Periodic Financial Reports
10-K · 2026-02-27
Corporate Changes & Voting Matters
8-K · 2026-02-26
Headlines
3 Stocks Under $50 We Keep Off Our Radar
StockStory · 1d ago
2 Growth Stocks to Stash and 1 We Turn Down
StockStory · 6d ago
Why Privia Health Group (PRVA) Is Getting Attention Now
Simply Wall St. · 17d ago
Privia Health Group (PRVA) Stock Looks Rich Against Current Earnings
Simply Wall St. · 18d ago
Dell and 4 More Stocks See Action From Activist Investors
Barrons.com · 18d ago
1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore
StockStory · 21d ago
3 Out-of-Favor Stocks We’re Skeptical Of
StockStory · 23d ago
Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest
StockStory · 26d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.